(Q35939591)

11 August 2017

1 reference

title

Behavioral and psychiatric adverse events associated with antiepileptic drugs commonly used in pediatric patients (English)

1 reference

11 August 2017

Tracy A Glauser

1

1 reference

11 August 2017

1 August 2004

1 reference

Journal of Child Neurology

11 August 2017

1 reference

11 August 2017

19 Suppl 1

1 reference

11 August 2017

S25-38

1 reference

The pharmacologic basis of antiepileptic drug action

11 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Voltage-activated calcium channels: targets of antiepileptic drug therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Topiramate and psychiatric adverse events in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Psychiatric adverse events during levetiracetam therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Psychotropic effects of carbamazepine in epilepsy: A double-blind comparison with phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Neuropsychological effects of epilepsy and antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Prophylactic diazepam or phenobarbitone in febrile convulsions: a prospective, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Anti-epileptic therapy and behaviour disturbances in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Side effects of phenobarbital in toddlers; behavioral and cognitive aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Barbiturate anticonvulsants: a neuropsychological and quantitative electroencephalographic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Prevention of recurrent febrile convulsions--a randomized therapeutic assay: sodium valproate, phenobarbital and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Gabapentin as add-on therapy in children with refractory partial seizures: a 24-week, multicentre, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Side effects of sodium valproate in monotherapy controlled by plasma levels: a study in 88 pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Treatment of Intractable Childhood Epilepsy with High-Dose Valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Long-term tolerability and efficacy of lamotrigine in pediatric patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Lamotrigine for the treatment of epilepsy in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Long-term safety and efficacy of lamotrigine (Lamictal) in paediatric patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Lamotrigine as add-on drug in children and adolescents with refractory epilepsy and mental delay: an open trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Lamotrigine treatment in childhood drug resistant epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Oxcarbazepine in the treatment of childhood epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Zonisamide in pediatric epilepsy: review of the Japanese experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Levetiracetam in refractory pediatric epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Efficacy and tolerability of levetiracetam in children aged 10 years and younger: a clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

A pilot study of topiramate in children with Lennox-Gastaut syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Topiramate as add-on drug in children, adolescents and young adults with Lennox-Gastaut syndrome: an Italian multicentric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

A pilot study of topiramate in the treatment of infantile spasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Reliability and validity of a Norwegian version of the quality of life in epilepsy inventory (QOLIE-89).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Topiramate: efficacy and tolerability in children according to epilepsy syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Topiramate for intractable childhood epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Tolerability of topiramate in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Cognitive and behavioral effects of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Treatment of epilepsy in the multiply handicapped

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380401900104

10.1177/088307380401900104

21 January 2018

Identifiers

DOI

0 references

PubMed ID

15526968

1 reference

PubMed ID

15526968